All these factors call for a deeper look at the biosimilar market trends emerging in the APAC region and identify potential winners. The APAC biosimilar market accounted for around 27% of the ...
Greater Effectiveness and Enhanced Safety Profiles of Biosimilars Compared to Their Reference Biologics Increasing Their Adoption Worldwid ...
The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of calls for price cuts that have led the big producers to slash prices ...
The Chosun Ilbo on MSN11d
Korean biotech firms race into $26 billion U.S. biosimilar marketSouth Korean biotech firms are targeting the $26 billion biosimilar market opening up as patents expire on more than 10 ...
“Amneal is building its position in the U.S. biosimilars market as this next wave of affordable medicines increases access for patients to biologics. Building on our first three successful ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback